Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 1
2011 1
2012 1
2013 2
2014 8
2015 7
2016 5
2017 7
2018 6
2019 9
2020 10
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

49 results
Results by year
Filters applied: . Clear all
Page 1
Peritoneal and upper genital tract tuberculosis.
Wagner A, Arsenić R, David M, Sehouli J, Vidosavljević D, Rohr I. Wagner A, et al. Among authors: arsenic r. Med Glas (Zenica). 2020 Feb 1;17(1):86-91. doi: 10.17392/1023-20. Med Glas (Zenica). 2020. PMID: 31663322 Free article.
Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment.
Busse A, Mochmann LH, Spenke C, Arsenic R, Briest F, Jöhrens K, Lammert H, Sipos B, Kühl AA, Wirtz R, Pavel M, Hummel M, Kaemmerer D, Baum RP, Grabowski P. Busse A, et al. Among authors: arsenic r. Cancers (Basel). 2020 Nov 19;12(11):3448. doi: 10.3390/cancers12113448. Cancers (Basel). 2020. PMID: 33228231 Free PMC article.
Prognostic Impact of Carboxylesterase 2 in Cholangiocarcinoma.
Goeppert B, Renner M, Singer S, Albrecht T, Zhang Q, Mehrabi A, Pathil A, Springfeld C, Köhler B, Rupp C, Weiss KH, Kühl AA, Arsenic R, Pape UF, Vogel A, Schirmacher P, Roessler S, Utku N. Goeppert B, et al. Among authors: arsenic r. Sci Rep. 2019 Mar 13;9(1):4338. doi: 10.1038/s41598-019-40487-9. Sci Rep. 2019. PMID: 30867471 Free PMC article.
Gastric neuroendocrine neoplasias: manifestations and comparative outcomes.
Felder S, Jann H, Arsenic R, Denecke T, Prasad V, Knappe-Drzikova B, Maasberg S, Wiedenmann B, Pavel M, Pascher A, Pape UF. Felder S, et al. Among authors: arsenic r. Endocr Relat Cancer. 2019 Sep;26(9):751-763. doi: 10.1530/ERC-18-0582. Endocr Relat Cancer. 2019. PMID: 31272081 Free PMC article.
Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?
Merola E, Rinke A, Partelli S, Gress TM, Andreasi V, Kollár A, Perren A, Christ E, Panzuto F, Pascher A, Jann H, Arsenic R, Cremer B, Kaemmerer D, Kump P, Lipp RW, Agaimy A, Wiedenmann B, Falconi M, Pavel ME. Merola E, et al. Among authors: arsenic r. Ann Surg Oncol. 2020 May;27(5):1348-1355. doi: 10.1245/s10434-019-08049-5. Epub 2019 Nov 12. Ann Surg Oncol. 2020. PMID: 31720931
IMP3 Expression in Borderline Tumors of the Ovary.
El-Balat A, Sänger N, Karn T, Becker S, Holtrich U, Muallem Z, Arsenic R. El-Balat A, et al. Among authors: arsenic r. Anticancer Res. 2017 Feb;37(2):583-588. doi: 10.21873/anticanres.11351. Anticancer Res. 2017. PMID: 28179304
Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3.
Merola E, Falconi M, Rinke A, Staettner S, Krendl F, Partelli S, Andreasi V, Gress TM, Pascher A, Arsenic R, Doglioni C, Kaemmerer D, Wiedenmann B, Pavel ME. Merola E, et al. Among authors: arsenic r. Am J Surg. 2020 Aug;220(2):284-289. doi: 10.1016/j.amjsurg.2020.03.009. Epub 2020 Mar 14. Am J Surg. 2020. PMID: 32209239
49 results